Emissive species for clinical imaging
View Patent ↗The present invention relates to materials and methods useful in the study of cells and species associated with cells. Materials of the present invention may include emissive, photostable organic molecules (e.g., conjugated polymers, conjugated oligomers) that are appropriately functionalized to interact with a cell with essentially no disruption in normal cell functioning. The present invention may be useful in, for example, cell imaging, cell tracking, in vivo monitoring of cellular events, drug delivery, and determination of biological species. In one embodiment, a conjugated polymer or oligomer may be internalized into a cell and may exhibit a strong and stable emissive signal, allowing the cell to be monitored under extensive microscopic conditions for extended periods of time.
1. A method of delivering a biological agent, comprising:
introducing a polymer having a conjugated backbone and bound to a biological agent or an oligomer having a conjugated backbone and bound to a biological agent into a cell.
2. The method as in claim 1 , wherein the polymer or the oligomer is emissive.
3. The method as in claim 1 , further comprising substantially simultaneously monitoring light emission from the polymer or the oligomer in the cell, wherein the light emission indicates delivery of the biological agent into the cell.
4. The method of claim 1 , wherein the polymer or oligomer is introduced into the cytoplasm.
5. The method of claim 1 , wherein the polymer or oligomer is introduced into the nucleus.
6. The method of claim 1 , further comprising exposing the polymer or the oligomer to a source of energy to cause an emission.
7. The method of claim 6 , wherein the emission is fluorescence, phosphorescence, or chemiluminescence.
8. The method of claim 6 , wherein the source of energy comprises electromagnetic radiation, electrical energy, sound energy, thermal energy, or chemical energy.
9. The method of claim 1 , wherein the polymer or oligomer is soluble in aqueous solutions.
10. The method of claim 1 , wherein the polymer or oligomer further comprises a biological recognition entity.
11. The method of claim 10 , wherein the biological recognition entity is a peptide.
12. The method of claim 10 , wherein the biological recognition entity is a nucleic acid.
13. The method of claim 10 , wherein the biological recognition entity is a small interfering RNA (siRNA).
14. The method of claim 10 , wherein the biological recognition entity is a carbohydrate.
15. The method of claim 10 , wherein the biological recognition entity is an antibody.
16. The method of claim 1 , wherein the polymer is a particle.
17. The method of claim 1 , wherein the polymer is polyphenylene, polythiophene, polyaniline, polypyrrole, poly(phenylenevinylene), poly(phenyleneethylnylene), substituted derivatives thereof, or combinations thereof.
18. The method of claim 1 , wherein the polymer or oligomer comprises a pendant group attached to the backbone.
19. The method of claim 18 , wherein the pendant group comprises a charged group.
20. The method of claim 18 , wherein the pendant group comprises an alkyl group, an alkoxy group, an aromatic group, a poly(ethylene glycol) group, a carbonyl group, a sulfate, an amine, an alcohol, a thiol, a cyanate, substituted derivatives thereof, or combinations thereof.
21. The method of claim 1 , wherein the polymer or oligomer is associated with a biological agent.